A-105

N-Acetylretigabine solution

100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

• 실험식(Hill 표기법): C₁₅H₁₆FN₃O
• CAS Number: 229970-68-7
• Molecular Weight: 273.31
• EC Number: 200-835-2
• UNSPSC 코드: 41116107
• NACRES: NA.24

속성

• Grade: certified reference material
• 양식: liquid
• 특징: (Snap-N-Spike^®)
• 포장: ampule of 1 mL
• 제조업체/상표: Cerilliant^®
• 농도: 100 μg/mL in acetonitrile
• 기술: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 응용 분야: clinical testing
• 형식: single component solution
• 저장 온도: −20°C
• SMILES string: NC1=C(NC(C)=O)C=CC(NCC2=CC=C(F)C=C2)=C1
• InChI: 1S/C15H16FN3O/c1-10(20)19-15-7-6-13(8-14(15)17)18-9-11-2-4-12(16)5-3-11/h2-8,18H,9,17H2,1H3,(H,19,20)
• InChI key: YGNSHYRMOVKKSL-UHFFFAOYSA-N

설명

일반 설명

A Certified Spiking Solution^® suitable for use in retigabine testing methods by LC/MS or GC/MS for applications in clinical toxicology, medication monitoring, urine drug testing, pharmaceutical research, or forensic analysis. N-Acetylretigabine is the primary urinary metabolite of retigabine, a new antiepileptic drug developed for treatment of partial seizures. Also known as ezogabine, the drug is marketed under the trade names Potiga^® in the US and Trobalt in the EU.

법적 정보

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation

Potiga is a registered trademark of Valeant Pharmaceuticals North America LLC

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

안전성 정보

• 픽토그램: GHS02,GHS07
• 신호어: Danger
• 유해 및 위험 성명서: H225,H302 + H312 + H332,H319
• 예방조치 성명서: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• Hazard Classifications: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• Storage Class Code: 3 - Flammable liquids
• WGK: WGK 2
• Flash Point (°F): 35.6 °F - closed cup
• Flash Point (°C): 2.0 °C - closed cup